CV Therapeutics, Inc. Balance Sheet

Balance Sheet FYE: 31-Dec

Assets9/30/20086/30/20083/31/200812/31/2007
Cash & Short Term Investments301.86274.74150.96179.04
Receivables - Total7.767.906.617.25
Inventories - Total20.8821.9122.4623.37
Total Current Assets347.66313.19187.54216.07
Net Property, Plant & Equipment15.6416.6418.2119.13
Total Assets391.99350.64228.02258.84
Liabilities    
Accounts Payable42.7433.9631.6313.16
Debt in Current LiabilitiesNANANANA
Total Current Liabilities61.6846.5331.6339.18
Long-Term Debt331.58346.50399.50399.50
Total Liabilities617.59557.51436.14444.23
Stockholder's Equity    
Minority InterestNANANANA
Preferred StockNANANANA
Common Stock0.060.060.060.06
Retained Earnings-1,329.45-1,304.07-1,299.78-1,267.88
Treasury StockNANANANA
Total Stockholders' Equity-225.60-206.87-208.11-185.40
Total Liabilities and Stockholders' Equity391.99350.64228.02258.84

CV Therapeutics, Inc. Balance Sheet


RYZONE FINANCIAL

BUSINESS
FUNDAMENTAL DATA